Skip to Content

APO F130 (Fenofibrate (Micronized) 130 mg)

Pill with imprint APO F130 is Green & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 130 mg. It is supplied by Apotex Corp..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 130 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO F130

Fenofibrate (Micronized)

Imprint:
APO F130
Strength:
130 mg
Color:
Green & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
National Drug Code (NDC):
60505-3121

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide